Journal of Endocrinological Investigation

, Volume 13, Issue 11, pp 931–935 | Cite as

Acromegaly and thymic hyperplasia: a case report

  • N. Bazzoni
  • B. Ambrosi
  • M. Arosio
  • M. Barbareschi
  • M. Losa
  • G. Faglia
Case Report


Growth hormone overproduction is characterized by increased size of visceral organs as well as growth of bone and soft tissues. We describe a case of a 23-year-old female acromegalic patient, who had been previously unsuccessfully operated upon by transsphenoidal pituitary surgery and then irradiated. In November 1987 a routine X-ray chest examination revealed a mediastinal mass, subsequently confirmed by CT scan. The patient underwent surgical removal of the mass: macroscopical aspect, histological sections and immunocytochemistry showed typical thymic structures without any evidence of neurosecretory activity. No GH-positive cells were found and only small amounts of immunoreactive GHRH like material (9.2 ng/g wet wg) were detected in the tumor extract. Before surgery plasma GHRH levels were not elevated (26 pg/ml); serum GH and IGF-I levels were 27.4 ± 4.9 μg/l and 191 nmol/l, respectively, and remained unchanged after surgery. These data ruled out a GHRH and/or GH ectopic production, confirming the primitive pituitary origin of acromegaly in this patient. It is likely that thymic hyperplasia may be explained by longstanding overproduction of GH and the young age of the patient.


Growth hormone insulin-like growth factor-l growth hormone releasing hormone acromegaly thymus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nabarro J.D.N. Acromegaly. Clin. Endocrinol. (Oxf.) 26: 481, 1987.CrossRefGoogle Scholar
  2. 2.
    Rosai J., Levine G.D. Tumors of the thymus. Atlas of tumor pathology. American Forces Institute of Pathology, Washington, 1976, p. 26.Google Scholar
  3. 3.
    Soudjian J.V., Moinar G.D., Silverstein M.N., Titus J.L Morphological studies of the thymus in acromegaly, diabetes mellitus, and Cushing’s syndrome. Metabolism 19: 40, 1970.Google Scholar
  4. 4.
    Sano T., Asa S.L, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical and morphological manifestations. Endocr. Rev. 9: 357, 1988.PubMedCrossRefGoogle Scholar
  5. 5.
    Arosio M., Moriondo P., Travaglini P., Ambrosi B., Beck Peccoz P., Conti Puglisi F., Secchi F., Faglia G. Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine and meter-goline. J. Clin. Endocrinol. Metab. 51: 454, 1980.PubMedCrossRefGoogle Scholar
  6. 6.
    De Toni G., Aicardi G., Bulgarelli R., Dalla Volta A., De Toni E., Gobessi I. Trattato di pediatria e puericultura. Edizioni Minerva Medica, Saluzzo, 1968, Vol. II, p. 358.Google Scholar
  7. 7.
    Arliss J., Scholes J., Dickson P.R., Messina J.J. Massive thymic hyperplasia in an adolescent. Ann. Thorac. Surg. 45: 220, 1988.PubMedCrossRefGoogle Scholar
  8. 8.
    Losa M., Wolfram G., Mojto G., Schopohl J., Spiess Y., Huber R., Müller O.A., Von Werder K. Presence of growth hormone-releasing hormone like-immunoreactivity in human tumors: characterization of immunological and biological properties. J. Clin. Endocrinol. Metab. 70: 62, 1990.PubMedCrossRefGoogle Scholar
  9. 9.
    Sternberger I.A. Immunocytochemistry. Prentice-Hall Inc., Englewood Cliffs, New York, 1974.Google Scholar
  10. 10.
    Levenston S.A., McKeel D.W., Buckley P.J., Deuschryver K., Greider M.H., Jaffe B.M., Daughaday W.H. Acromegaly and Cushing’s syndrome associated with a foregut carcinoid tumor. J. Clin. Endocrinol. Metab. 53: 682, 1981.CrossRefGoogle Scholar
  11. 11.
    Schulte H.M., Benker G., Windeck R., Olbricht T., Reinwein D. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing. J. Clin. Endocrinol. Metab. 61: 585, 1985.PubMedCrossRefGoogle Scholar
  12. 12.
    Hofman W.J., Moller P., Otto H.F. Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study. Klin. Wochenschr. 65: 53, 1987.CrossRefGoogle Scholar
  13. 13.
    Iudd R. L. Massive thymic hyperplasia with myoid cell differentiation. Hum. Pathol. 78: 1180, 1987.Google Scholar
  14. 14.
    Rosati A., Pisascane A., Palmieri B., Ruco L.P., Baroni C.D. True thymic hyperplasia: presence of vimentin+/desmin+ cells. Proceedings of XVII International Congress of the International Academy of Pathology and the 8th World Congress of Academic and Environmental Pathology. Dublin, September 4–9, 1988, p. 111. (Abstract)Google Scholar
  15. 15.
    Talwar G.P., Hanjan S.N.S., Kidwai Z., Gupta P.D., Mehrotra N.N., Saxena R., Bhattarai Q. Growth hormone action on thymus and lymphoid cells. In: Pecile A., Muller E.E. (Eds.), Growth hormone and related peptides. Elsevier Science Publisher B.V., New York, 1976, p. 104.Google Scholar
  16. 16.
    Lesniak M.A., Roth J., Gordon P., Gavin J.R. III. Human growth hormone radioreceptor assay using cultured human lymphocytes. Nature 241: 20, 1973.Google Scholar
  17. 17.
    Kelley K.W., Brief S., Westly H.J., Novakovsky J., Bechtel P.J., Simon J., Walker E.B. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci. USA 83: 5663, 1986.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Arrenbrecht S. Specific binding of growth hormone to thymocytes. Nature 252: 255, 1974.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1990

Authors and Affiliations

  • N. Bazzoni
    • 1
  • B. Ambrosi
    • 1
  • M. Arosio
    • 1
  • M. Barbareschi
    • 2
  • M. Losa
    • 3
  • G. Faglia
    • 1
  1. 1.Istituto di Scienze EndocrineUniversity of MilanoMilanoItaly
  2. 2.3a Cattedra di Anatomia Patologica e IstopatologiaUniversity of MilanoMilanoItaly
  3. 3.Cattedra di Neurotraumatologia, Ospedale S. RaffaeleUniversity of MilanoMilanoItaly

Personalised recommendations